Neueon Corporation FY26 Results: ₹32,618 Cr Consolidated Loss, Qualified Audit
Neueon Corporation Limited has reported significant financial losses for FY26, with consolidated net loss of ₹32,618.12 crore and standalone loss of ₹13,346.90 crore. The auditors issued qualified opinions due to inadequate impairment testing procedures and material weakness in internal controls, while the company completed its CIRP resolution process with NCLT approval in October 2024.

*this image is generated using AI for illustrative purposes only.
Neueon Corporation Limited (formerly Neueon Towers Limited) has released its audited financial results for FY26, reporting significant losses on both standalone and consolidated basis. The company posted a consolidated net loss of ₹32,618.12 crore and standalone net loss of ₹13,346.90 crore, reflecting the impact of asset impairments and resolution process costs.
Financial Performance Overview
The company's financial performance shows substantial deterioration across key metrics. On a standalone basis, total income increased to ₹1,586.39 crore from ₹556.64 crore in the previous year, primarily driven by higher revenue from operations at ₹1,572.20 crore compared to ₹539.53 crore in FY25.
| Particulars: | FY26 (₹ Crore) | FY25 (₹ Crore) | Change |
|---|---|---|---|
| Total Income: | 1,586.39 | 556.64 | +185% |
| Total Expenses: | 14,933.29 | 9,630.28 | +55% |
| Net Loss (Standalone): | (13,346.90) | (9,073.67) | -47% |
| Net Loss (Consolidated): | (32,618.12) | (9,073.68) | -259% |
| Earnings Per Share: | (23.60) | (16.05) | -47% |
Qualified Audit Opinion and Asset Impairment
ASKM & Co., Chartered Accountants, issued a qualified audit opinion highlighting critical concerns. The primary qualification relates to the company's failure to conduct proper impairment testing of Property, Plant and Equipment (PPE), investments, and other financial assets as required under Ind AS 36.
The company recognized an impairment loss of ₹58,748.44 crore on fixed assets, but the auditors noted that this assessment lacked adequate documentation and appropriate determination of recoverable amount. The auditors stated they were unable to determine whether any adjustment is necessary to the carrying value of assets due to insufficient audit evidence regarding assumptions used in estimating future cash flows and discount rates.
CIRP Resolution and Corporate Restructuring
Neueon Corporation was admitted into the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016, by an order dated November 21, 2018, from the National Company Law Tribunal (NCLT), Hyderabad Bench. A resolution plan submitted by a consortium led by Preca Solutions India Private Limited was approved by the NCLT on October 23, 2024.
| Resolution Plan Details: | Status |
|---|---|
| NCLT Approval Date: | October 23, 2024 |
| New Board Reconstitution: | December 2, 2024 |
| Last Tranche Payment: | August 28, 2025 |
| Share Capital Reduction: | ₹10 to ₹1 per share |
| Monitoring Committee: | November 4, 2024 |
Going Concern and Internal Control Issues
The auditors highlighted material uncertainty regarding the company's ability to continue as a going concern. The company incurred cash losses of ₹7,328.88 crore during FY26 and ₹201.79 crore in the preceding year. The ability to continue operations depends on successful implementation of the remaining terms of the resolution plan and revival of operational and financial performance.
Regarding internal financial controls, the auditors identified material weakness in the company's system for periodic impairment testing of assets. The company stated it is establishing a robust internal control framework now that the new Board and management are operational.
Regulatory Compliance and Board Approval
The Board of Directors approved the audited standalone and consolidated financial results at their meeting held on May 1, 2026. The company published newspaper advertisements in Financial Express (English) and Nava Telangana (Regional) on May 2, 2026, intimating stock exchanges about the publication of these results as required under regulatory compliance.
Will the Preca Solutions-led consortium be able to successfully turn around operations and achieve profitability by the final tranche payment deadline of August 2025?
How will the massive ₹58,748 crore asset impairment affect the company's ability to secure future financing and investment for business revival?
What specific operational strategies will the new management implement to reverse the trend of increasing cash losses and restore investor confidence?




























